NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy
U.S. STOCKS ON THE MOVE-United Airlines Holdings, Energy companies, Tesla
U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin
U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge
Genprex rises as diabetes gene therapy shows promise in animal tests
U.S. STOCKS ON THE MOVE-Warner Bros Discovery, Energizer Holdings, Target
U.S. STOCKS ON THE MOVE-Ardent Health, Intuit, Galmed Pharma
U.S. STOCKS ON THE MOVE-Cloudflare, Legence, Lumentum
Genprex rises after winning US patent for cancer drug combination
Brief: Genprex Gets EU Nod To Grant Patent For REQORSA And PD-1 Antibody Combo To Treat Cancer
Brief: Genprex Announces Registered Direct Offering of up to $8.1 Million Priced At-The-Market Under Nasdaq Rules
Brief: Genprex Issues Stockholder Letter And Provides 2025 Corporate Update
Brief: Genprex - Lincoln Park To Purchase Up To $12.5 Million In Genprex Shares
Genprex Inc expected to post a loss of 41 cents a share - Earnings Preview
Brief: Genprex Collaborators Report Positive Preclinical Data On The Use Of Reqorsa Gene Therapy
Brief: Genprex Signs Agreement With New York University Langone Health